WO2025172892 - MODIFIED PROTEINS AND METHODS
National phase entry is expected:
Publication Number
WO/2025/172892
Publication Date
21.08.2025
International Application No.
PCT/IB2025/051557
International Filing Date
13.02.2025
Title **
[English]
MODIFIED PROTEINS AND METHODS
[French]
PROTÉINES MODIFIÉES ET MÉTHODES
Applicants **
GLAXOSMITHKLINE BIOLOGICALS SA
Inventors
COZZI, Roberta
ROSINI, Roberto
ADAMO, Roberto
ROMANO, Maria Rosaria
MAIONE, Domenico
CAPPELLI, Luigia
CINELLI, Paolo
WAHOME, Newton Muchugu
PHOGAT, Sanjay Kumar
KOWARIK, Michael Thomas
LIPOWSKY, Gerd Martin
MARKOVIC-MÜLLER, Sandra
CARRANZA SANDMEIER, Maria Paula
HERWIG, Stefan
MÜLLER, Fabian Oliver
KUHN, Levi
Priority Data
63/554,486
16.02.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3472 | |
| EPO | Filing, Examination, Granting | 19414 | |
| Japan | Filing, Examination, Granting | 2587 | |
| South Korea | Filing, Examination, Granting | 2951 | |
| USA | Filing, Examination, Granting | 12840 |
Total:
41,264
Contact Us
Abstract[English]
The present invention relates to the field of modified nanoparticles, immunogenic compositions and vaccines comprising the modified nanoparticles, their manufacture and the use of such compositions in medicine.[French]
La présente invention concerne le domaine des nanoparticules modifiées, des compositions immunogènes et des vaccins comprenant les nanoparticules modifiées, leur fabrication et l'utilisation de telles compositions en médecine.